Evidence map›Paper›PMID 40061954›Full record

ArticleFrontiers in pharmacology2025

Exploration the therapeutic effects of sodium houttuyfonate combined with penicillin G on methicillin resistant

Yujie Li, Shunjie You, Sheng Li, Si Li, Aimin Jia, Xiaoyan Xiang, Shi Shen, Yan Cai

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yujie Li *Genetic and Prenatal Diagnosis Center, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.
Shunjie You *Burn and Plastic Surgery Department of Ziyang Central Hospital, Ziyang, China.
Sheng LiBurn and Plastic Surgery Department of Ziyang Central Hospital, Ziyang, China.
Si LiAffiliated Hospital, North Sichuan Medical College, Nanchong, China.
Aimin JiaAffiliated Hospital, North Sichuan Medical College, Nanchong, China.
Xiaoyan XiangAffiliated Hospital, North Sichuan Medical College, Nanchong, China.
Shi ShenDepartment of Orthopedics, The Affiliated Hospital, Southwest Medical University, Luzhou, China.
Yan CaiGenetic and Prenatal Diagnosis Center, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methicillin resistant Methods: Evaluating the antibacterial effect of drugs through Result: The MIC of SH and PNC are 60-80 μg/mL and 40-70 U/mL, respectively. The FICI of the combined group is 0.375-0.5625, and the optimal drug ratio is SH20 μg/mL + PNC15u/mL. The number of central granulocytes infiltrated in the combined group was less than that in other groups, and the levels of IL-6 and TNF-α were significantly reduced. In addition, the collagen fibers in the wound were significantly increased. Thirteen target genes were predicted through network pharmacology, among which the core targets were IL1B, IL6, MMP9, IFNG, and TNF. SH and PNG have shown good binding potential with various targets in molecular docking. Among the 83 potential pathways of action, IL-17 signaling pathway is considered a key pathway for promoting wound healing. Conclusion: Sodium houttuyfonate combined with penicillin G can inhibit bacterial growth in MRSA infected wounds in rats, reduce neutrophil infiltration, promote collagen fiber generation in wounds, and decrease the expression levels of inflammatory factors IL-6 and TNF-α in the blood of rats after MRSA infection. It promotes wound healing through multiple targets and pathways, and preliminarily reveals the drug's targets and molecular mechanisms.

Indexed as

MRSAnetwork pharmacologypenicillin Gsodium houttuyfonatewound healing

Identifiers

PMID40061954
PMCPMC11885298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.